Clinical trial
Two Hypoabsorption Techniques for the Treatment of Type III Obesity (OASIS)
Opening soon · Not applicable · 0 countries · Registry ID NCT05948852
Opening soonNot applicableInterventional
What this study is about
This study aims to compare the percentage of total weight lost in long-term follow-up after two surgical interventions (SADIS and OAGB) in patients with morbid obesity BMI between 45-49.9.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity, Morbid
Full registry criteria
Inclusion Criteria: * Patients over 18 and under 65 who meet criteria for bariatric surgery. * Maximum BMI between 45 and 50 kg/m2 and indication for surgery in a time * Signature of the informed consent of the study * Patients suitable for laparoscopic surgery Exclusion Criteria: * Previous bariatric surgery * 2-stage surgery * Contraindication for hypoabsorptive surgery due to previous pathology: inflammatory bowel disease, transplant recipient or transplant candidate, previous intestinal resection surgery * Other associated surgical procedures in the same intervention. * Conversion to laparotomy
Treatments and study arms
metabolic surgery (SADIS and OAGB)
Procedure
TWO HYPOABSORPTION TECHNIQUES FOR THE TREATMENT OF TYPE III OBESITY (BODY MASS INDEX BETWEEN 45 - 49.9 KG/M2): SINGLE ANASTOMOSE DUODENAL SWITCH (SADI-S) AND SINGLE ANASTOMOSE GASTRIC BY-PASS (OAGBP).
Primary outcomes
the percentage of total weight loss (%TWL) of the patients after surgeryBaseline, 1 year, 3 year, 5 year after SADI-S and OAGBP surgery
Study locations
0 locations were listed when this page was built. The first 40 are shown.
No public site location was included in this record. Check the original registry for updates.